Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
BCD-264
DRUG
2 trials
Sponsors
Biocad
Conditions
Healthy
Multiple Myeloma
Phase 1
A Study to Assess the PK, PD, Safety and Immunogenicity of Single IV Infusion of BCD-264 and Darzalex in Healthy Subjects
Completed
NCT05974969
Biocad
Healthy
Start: 2023-05-17
End: 2023-08-15
Updated: 2023-11-18
Phase 3
A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma
Recruiting
NCT06296121
Biocad
Multiple Myeloma
Start: 2023-12-21
End: 2026-07-31
Target: 252
Updated: 2024-03-06